Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice
about
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate formMultiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virusGenetic determinants of dengue type 4 virus neurovirulence for miceCharacterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia virusesHumanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In VivoReplication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulumVirus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccineC-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins.Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts.
P2860
Q27480299-A1A2717C-259C-4CAE-BD56-222883DAFEF6Q27480738-BC2CE839-F2C6-4AFE-8681-49193D9378B6Q27486073-D88402D6-9282-4050-B338-7C7FCA39983FQ27486074-02211078-8C6C-4DE3-BD07-9F4B84E0FE1BQ27486404-58C981BF-EE55-44DD-8563-D1823E201003Q27487570-3716B388-1C4C-40CC-A9D1-008671E83A56Q33201423-AE5407F4-1055-40D8-B83A-BA7EDA14AEA4Q33542433-CF2978BD-1DAA-4CA2-8595-5F677EB88147Q33826597-F812EBBB-DACA-4167-8D63-668EA0F449CDQ34262245-AC8074EC-FE18-4C8B-A004-BFFE94FD29FDQ34540907-A5939496-19D4-4536-9A6A-FE525643C50DQ34746139-789A3A6B-083A-48EF-91BF-20A91E28283DQ37285066-522BB36A-5BE3-4D74-A6E8-850F8F4694FBQ37903445-2158BE8E-FBE6-42B6-894C-E7BE9029637FQ39118535-047F7DB2-F240-40D6-A3FD-480178D4ED79
P2860
Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice
description
1991 nî lūn-bûn
@nan
1991 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մարտին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@ast
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@en
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@nl
type
label
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@ast
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@en
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@nl
prefLabel
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@ast
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@en
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@nl
P2093
P2860
P1433
P1476
Carboxy-terminally truncated d ...... creased immunogenicity in mice
@en
P2093
P2860
P304
P577
1991-03-01T00:00:00Z